Progressive
retinal atrophy, or PRA as it is frequently termed, is a long
recognized, hereditary, blinding disorder. It is inherited as a simple
autosomal recessive in most breeds. The first modern description of
this problem was in Gordon Setters in Europe, in 1911, but since then
PRA has been recognized in most purebred dogs. Millichamp et al. In
1988, described PRA in Tibetan Terriers. Also in 1988, it was found
that PRA in Cockers, Poodles and Labradors was the result of a mutation
at the same gene locus in all these breeds.
PRA is a disease
of the retina. This tissue, located inside the back of the eye,
contains specialized cells called photoreceptors that absorb the light
focused on them by the eye’s lens, and converts that light, through a
series of chemical reactions into electrical nerve signals. The nerve
signals from the retina are passed by the optic nerve to the brain
where they are perceived as vision. The retinal photoreceptors are
specialized into rods, for vision in dim light (night vision), and
cones for vision in bright light (day and color vision). PRA usually
affects the rods initially, and then cones in later stages of the
disease. In human families, the diseases equivalent to PRA (in dogs)
are termed retinitis pigmentosa.
In all canine
breeds PRA has certain common features. Early in the disease, affected
dogs are nightblind, lacking the ability to adjust their vision to dim
light; later their daytime vision also fails. As their vision
deteriorates, affected dogs will adapt to their handicap as long as
their environment remains constant, and they are not faced with
situations requiring excellent vision. At the same time the pupils of
their eyes become increasingly dilated, in a vain attempt to gather
more light, causing a noticeable "shine" to their eyes; and the lens of
their eyes may become cloudy, or opaque, resulting in a cataract.
The big
difference in PRA among breeds is in the age of onset and the rate of
progression of the disease. Certain breeds, notably including the
Collie, the Irish Setter, the Norwegian Elkhound and the Miniature
Schnauzer, have early onset forms. In these breeds the disease results
from abnormal or arrested development of the photoreceptors—the visual
cells in their retina, and affects pups very early in life. In other
breeds, including the Miniature Poodle, the English and American Cocker
Spaniel, and the Labrador Retriever, and many other breeds, including
the Tibetan Terrier, Tibetan Spaniel, and Lhasa Apso, PRA is much later
in onset. Affected dogs in these breeds appear normal when young, but
develop PRA as adults.
Diagnosis of PRA
is normally made by ophthalmoscopic examination. This is undertaken
using an instrument called an indirect ophthalmoscope, and requires
dilatation of the dog’s pupil by application of eyedrops. Broadly
speaking, all forms of PRA have the same sequence of ophthalmoscopic
changes: increased reflectivity (shininess) of the fundus (the inside
of the back of the eye, overlain by the retina); reduction in the
diameter and branching pattern of the retina’s blood vessels; and
shrinking of the optic nerve head (the nerve connecting the retina to
the brain). These changes occur in all forms of PRA, but at different
times in the different breed-specific forms. Usually by the time the
affected dog has these changes there is already significant evidence of
loss of vision.
Fig. 1. The normal retina.
Note the many prominent blood vessels
Fig. 2. A mid-stage PRA retina.
Notice how the vascularity has been markedly reduced.
Confirmation of the
diagnosis can be undertaken by electroretinography. This is an
electrical measurement of retinal function somewhat similar to an
electrocardiographic test of heart function, but with two differences:
the electroretinogram (ERG) can only be recorded as a response to a
flash of light (ie: it is not a free running signal like the EKG); and
accurate recording of the ERG requires that the dog be anesthetized. In
all dogs showing clinical evidence of PRA, the ERG is severely
diminished or extinguished. The ERG can also be used for early
diagnosis of specific forms of PRA, that is to detect PRA-affected dogs
before they demonstrate clinical evidence of disease. This requires
very carefully controlled ERG recording conditions, and a well defined
understanding of the age of onset and rate of change of ERG dysfunction
in the specific form of PRA under consideration.